Fortress Biotech, Inc. Income Taxes Paid
Fortress Biotech, Inc. (FBIO) reported Income Taxes Paid of $147.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-13
- Fortress Biotech, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Fortress Biotech, Inc. income taxes paid, net for the quarter ending 2025-09-30 was $0.00.
- Fortress Biotech, Inc. income taxes paid, net for the quarter ending 2024-12-31 was $5.00K.
- Fortress Biotech, Inc. income taxes paid, net for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Fortress Biotech, Inc. income taxes paid, net for fiscal 2025 was $49.00K, a 59.17% decline from fiscal 2024.
- Fortress Biotech, Inc. income taxes paid, net for fiscal 2024 was $120.00K.
- Fortress Biotech, Inc. income taxes paid, net for fiscal 2023 was -$55.00K, a 106.41% decline from fiscal 2022.
- Fortress Biotech, Inc. income taxes paid, net for fiscal 2022 was $858.00K, a 13.60% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $147.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $49.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $49.00K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $49.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.00K derived: sum of 2 quarters · filed 2026-03-31 | $120.00K derived: sum of 3 quarters · filed 2026-03-31 | $120.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $115.00K derived: sum of 2 quarters · filed 2025-11-14 | $115.00K 10-Q · filed 2025-11-14 | $77.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $115.00K 10-Q · filed 2025-08-14 | $77.00K derived: sum of 3 quarters · filed 2025-08-14 | $112.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | -$38.00K derived: sum of 2 quarters · filed 2025-03-31 | -$3.00K derived: sum of 3 quarters · filed 2025-03-31 | $49.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.00K derived: sum of 2 quarters · filed 2025-03-31 | $49.00K derived: sum of 3 quarters · filed 2025-03-31 | -$55.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $87.00K derived: sum of 2 quarters · filed 2024-11-14 | -$17.00K 10-Q · filed 2024-11-14 | -$621.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$52.00K 10-Q · filed 2024-08-13 | -$656.00K derived: sum of 3 quarters · filed 2024-08-13 | $640.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$104.00K 10-Q · filed 2024-05-15 | -$708.00K derived: sum of 2 quarters · filed 2024-05-15 | $588.00K derived: sum of 3 quarters · filed 2024-05-15 | $647.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $692.00K derived: sum of 2 quarters · filed 2024-03-28 | $751.00K derived: sum of 3 quarters · filed 2024-03-28 | $858.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.35M derived: sum of 2 quarters · filed 2023-11-14 | $1.46M 10-Q · filed 2023-11-14 | $1.79M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $166.00K 10-Q · filed 2023-08-14 | $498.00K derived: sum of 3 quarters · filed 2023-08-14 | $655.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $107.00K 10-Q · filed 2023-05-15 | $439.00K derived: sum of 2 quarters · filed 2023-05-15 | $596.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.10M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $489.00K derived: sum of 2 quarters · filed 2023-03-31 | $993.00K derived: sum of 3 quarters · filed 2023-03-31 | $993.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $661.00K derived: sum of 2 quarters · filed 2022-11-14 | $661.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $504.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |